Hematopoietic Neoplasm: Clinical Trials

4 trials for Hematopoietic Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Unknown 1
Phase 11Unknown 1

Follow Hematopoietic Neoplasm: new trials by email Literature Review of Hematopoietic Neoplasm trials Research Report on Hematopoietic Neoplasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
Methotrexate Injectable Solution - Graft Vs Host Disease, Hematopoietic Neoplasm
Phase 1 / Phase 2UnknownUniversity of Sao Paulo General Hospital472020-10-072021-09-14
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
SAR302503 - Hematopoietic Neoplasm
Phase 2TerminatedBristol-Myers Squibb972012-04-302026-07-16
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
SAR302503 - Hematopoietic Neoplasm
Phase 2CompletedBristol-Myers Squibb812011-10-012025-03-05
Phase 2 Study of SAR302503 in Patients With Myelofibrosis
SAR302503 - Hematopoietic Neoplasm
Phase 2CompletedBristol-Myers Squibb302011-08-012025-03-05

Narrower conditions

Hematologic Neoplasms (4)  ·  Graft vs Host Disease (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Immune System Diseases (1)

Interventions

fedratinib (3)

Sponsors

Bristol-Myers Squibb (3)  ·  University of Sao Paulo General Hospital (1)

Countries

United States (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Giancarlo Fatobene, MD (1)

Results publications

PMID 28602585